Steve O'Loughlin
2023
In 2023, Steve O'Loughlin earned a total compensation of $1.5M as Chief Financial Officer at Actinium Pharmaceuticals, a 1% increase compared to previous year.
Compensation breakdown
| Bonus | $170,000 |
|---|---|
| Option Awards | $900,000 |
| Salary | $420,000 |
| Total | $1,490,000 |
O'Loughlin received $900K in option awards, accounting for 60% of the total pay in 2023.
O'Loughlin also received $170K in bonus and $420K in salary.
Rankings
In 2023, Steve O'Loughlin's compensation ranked 801st out of 3,006 executives tracked by ExecPay. In other words, O'Loughlin earned more than 73.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 801 out of 3,006 | 73rd |
Division Manufacturing | 470 out of 1,650 | 72nd |
Major group Chemicals And Allied Products | 320 out of 918 | 65th |
Industry group Drugs | 312 out of 881 | 65th |
Industry Pharmaceutical Preparations | 208 out of 637 | 67th |
Source: SEC filing on November 5, 2024.
O'Loughlin's colleagues
We found one more compensation record of an executive who worked with Steve O'Loughlin at Actinium Pharmaceuticals in 2023.
2023
Sandesh Seth
Actinium Pharmaceuticals
Chief Executive Officer
News
Actinium Pharmaceuticals CEO Sandesh Seth's 2023 pay rises 17% to $4.7M
November 5, 2024
Actinium Pharmaceuticals CEO Sandesh Seth's 2022 pay jumps 72% to $4M
November 9, 2023
Actinium Pharmaceuticals CEO Sandesh Seth's 2021 pay jumps 27% to $2.3M
November 21, 2022
Actinium Pharmaceuticals CEO Sandesh Seth's 2019 pay slips 20% to $1.1M
October 7, 2020